{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-115672","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2026-10-14T01:49:11+00:00","discovered_at":"2026-10-14T10:05:01.238974+00:00","generated_at":"2026-10-14T10:05:40.872127+00:00","sec_items":["1.01","1.02","7.01","8.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Liquidia to pay $380.7M to United Therapeutics, resolving all litigation and keeping YUTREPIA in PAH","bullets":["Settlement resolves all six lawsuits with UTHR, including U.S. Patent 11,826,327, trade secret and antitrust cases; Liquidia will not appeal Delaware ruling.","Liquidia will pay UTHR net $175.0M within 30 business days plus $145.4M in two $72.7M installments due Jan 31 and Apr 30, 2027.","Liquidia will remove PH-ILD indication from YUTREPIA label and cease promotion; YUTREPIA remains marketed for PAH.","Q3 2026 preliminary YUTREPIA net sales were $222.7M; cash and equivalents were $396.1M as of Sept 30, 2026.","Liquidia also pays $60.3M to Sandoz, Henderson and PBM to settle RareGen antitrust interests; HCR minimum cash covenant rises to $45.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-115672","json":"https://secwatch.observer/filing/0001104659-26-115672.json","markdown":"https://secwatch.observer/filing/0001104659-26-115672.md","text":"https://secwatch.observer/filing/0001104659-26-115672.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465926115672/0001104659-26-115672-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465926115672/tm2627557d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-14T10:05:40.872127+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}